$21 price target initiated: "Baird initiated coverage on Chembio Diagnostics Inc (NASDAQ: CEMI) with an Outperform rating. The price target for Chembio Diagnostics is set at $21.00. For the first quarter, Chembio Diagnostics had an EPS of ($0.25), compared to year-ago quarter EPS of ($0.14). The stock has a 52-week-high of $15.89 and a 52-week-low of $2.25. Chembio Diagnostics's stock last closed at $10.87 per share."
Market Data 
Markets 
AI
